Radiation before possible breast surgery for early ER-positive cancer
Part of Cancer, Skin clinical trials.
This study gives radiation to the breast before surgery to see if some people can safely delay or even skip surgery. It targets women with a small, node-negative, ER-positive breast cancer with low genetic risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female and age 50 or older
- You are postmenopausal (or had ovaries removed or no period for over 12 months)
- Your cancer has been proven as invasive breast cancer by biopsy within the last 12 weeks
- Your tumor is in one area only, and is 2 cm or smaller on exam and breast ultrasound
- There are no signs of cancer in the underarm lymph nodes on exam and breast ultrasound
- Your tumor is ER-positive (80% or more), PR-positive (20% or more), HER2-negative, no cancer spread in blood vessels in the biopsy, and low Oncotype DX score (18 or less)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests giving radiation to the tumor area before surgery for women with early-stage, hormone-sensitive breast cancer. The idea is to see if giving radiation first can help protect healthy tissue while still being effective.
This study tests whether giving a single dose of radiation before breast surgery can be safe and effective for early-stage breast cancer. It may help by shrinking or treating the tumor right before the operation, depending on your case.
This trial tests a single, shorter course of radiation given before breast surgery for people with low-risk, hormone-receptor–positive breast cancer. It may help treat the breast tumor while reducing the number and length of radiation treatments.
This trial tests whether giving radiation therapy along with other cancer treatments before surgery can help early-stage breast cancer that has spread to the lymph nodes. The goal is to see if this approach is safe and works better than standard treatment.
This trial tests adding radiation therapy to chemotherapy before surgery for people with locally advanced breast cancer that did not shrink enough with chemo alone. It may help improve outcomes for those with luminal (HER2-negative) or triple-negative types.
This trial is for women 50 and older with early-stage, hormone-positive or HER2-positive breast cancer. It tests whether it is safe to skip radiation therapy after a lumpectomy if an MRI before surgery shows the breast tissue looks a certain way.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.